ECSP066281A - Pirazolinas como antagonistas de par-1 para el tratamiento de enfermedades cardiocirculatorias - Google Patents

Pirazolinas como antagonistas de par-1 para el tratamiento de enfermedades cardiocirculatorias

Info

Publication number
ECSP066281A
ECSP066281A EC2006006281A ECSP066281A ECSP066281A EC SP066281 A ECSP066281 A EC SP066281A EC 2006006281 A EC2006006281 A EC 2006006281A EC SP066281 A ECSP066281 A EC SP066281A EC SP066281 A ECSP066281 A EC SP066281A
Authority
EC
Ecuador
Prior art keywords
treatment
diseases
pirazolinas
par
antagonists
Prior art date
Application number
EC2006006281A
Other languages
English (en)
Inventor
Walter Huebsch
Nicole Diedrichs
Swen Allerheilingen
Dirk Brohm
Britta-Nicole Froehlen
Christoph Gerdes
Mark Jean Gnoth
Heike Heckroth
Elisabeth Perzborn
Elke Stahl
Verena Voehringer
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of ECSP066281A publication Critical patent/ECSP066281A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a pirazolinas de fórmula (I) en la que E representa metileno, NH, un átomo de oxígeno o un átomo de azufre, y R2 representa un grupo de fórmula (II), y a procedimientos para su preparación, así como su uso para la preparación de fármacos para el tratamiento y/o la profilaxis de enfermedades, especialmente de enfermedades cardiocirculatorias como, por ejemplo, enfermedades tromboembólicas. (II).
EC2006006281A 2003-07-15 2006-01-12 Pirazolinas como antagonistas de par-1 para el tratamiento de enfermedades cardiocirculatorias ECSP066281A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10331951 2003-07-15
DE102004010545A DE102004010545A1 (de) 2003-07-15 2004-03-04 Pyrazoline

Publications (1)

Publication Number Publication Date
ECSP066281A true ECSP066281A (es) 2006-07-28

Family

ID=34088638

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006281A ECSP066281A (es) 2003-07-15 2006-01-12 Pirazolinas como antagonistas de par-1 para el tratamiento de enfermedades cardiocirculatorias

Country Status (4)

Country Link
CN (1) CN1852710A (es)
DE (1) DE102004010545A1 (es)
EC (1) ECSP066281A (es)
IL (1) IL173136A0 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104086501B (zh) * 2014-07-23 2016-02-17 张远强 一种par-1拮抗剂、其制备方法和用途
CN111892585A (zh) * 2020-08-05 2020-11-06 杭州维坦医药科技有限公司 作为p2x3受体拮抗剂的n-甲酰胺基吡唑啉类衍生物及应用

Also Published As

Publication number Publication date
IL173136A0 (en) 2006-06-11
DE102004010545A1 (de) 2005-02-24
CN1852710A (zh) 2006-10-25

Similar Documents

Publication Publication Date Title
CU23464B7 (es) (1,8)naftidirin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia
ECSP066717A (es) Compuestos de quinolina sustituidos
ECSP055676A (es) Piperazinas heterocíclicas sustituidas para el tratamiento de la esquizofrenia
ECSP066886A (es) Compuestos y métodos para el tratamiento de dislipidemia
UY29300A1 (es) Compuestos quimicos
ECSP088329A (es) Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8
UY28990A1 (es) Nuevos derivados de benceno 1, 3-amino carbonilo como inhibidores de b-raf, composiciones farmacéuticas que los contienen, procesos de preparación y uso.
CO5700767A2 (es) Procedimiento de tratamiento de rechazo de transplantes
SV2009003299A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa
ECSP056210A (es) Preparación y uso de derivados de alquilarilo para el tratamiento de la obesidad
CY1109998T1 (el) Ενδυναμωτες υποδοχεων γλουταμινικου
GT200800187A (es) Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos
CO6511240A2 (es) Ligandos sigma para la prevención o el tratamiento de dolor inducido por quimioterapia
ECSP056006A (es) Composiciones farmacéuticas que comprenden una combinación de rapamicina o su derivado y pimecrolimus para el tratamiento de enfermedades inflamatorias e inmunológicamente mediadas
UY30577A1 (es) Derivados de éter diarilico y usos de los mismos
BRPI0519267A2 (pt) derivado de quinolina, seu uso, produÇço e medicamento contendo o mesmo
UY30706A1 (es) Diaril, dipiridinil y arilpiridinil derivados y usos de los mismos
UY28313A1 (es) Nonadepsipeptidos acilados
DOP2006000024A (es) Tiazolidinonas, su preparación y su uso como medicamento
UY29189A1 (es) Nonadepsipeptidos acilados ii
BRPI0509667B8 (pt) composto, processo para a preparação de um composto de fórmula (i), medicamento e uso de um composto
UY28247A1 (es) Compuestos de benzopirano para uso en el tratamiento y la prevención de afecciones relacionadas con la inflamación.
CR7735A (es) Piperizinas heterociclicas sustituidas para el tratamiento de la esquizofrenia
ECSP066281A (es) Pirazolinas como antagonistas de par-1 para el tratamiento de enfermedades cardiocirculatorias
UY27733A1 (es) Derivados de ciclopenteno.